Johnson & Johnson has proposed a $5.5 billion settlement to resolve remaining legal claims alleging that its talc products caused ovarian cancer. The proposed agreement covers approximately 76,000 claims, representing nearly all remaining talc-related litigation against the company.
The drugmaker has spent more than a decade fighting lawsuits related to its talc products. According to the company, the newly proposed settlement is contingent upon securing the agreement of at least 95 percent of the remaining claimants.
In-depth summary · AI, neutral